| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
8,992 |
7,531 |
$1.08M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
7,596 |
6,405 |
$665K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,944 |
1,860 |
$205K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,705 |
1,652 |
$179K |
| 99215 |
Prolong outpt/office vis |
893 |
821 |
$152K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,562 |
1,355 |
$149K |
| 86328 |
|
2,522 |
2,248 |
$108K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
907 |
873 |
$106K |
| 92552 |
|
2,559 |
2,463 |
$63K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
3,858 |
3,462 |
$55K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,929 |
3,434 |
$51K |
| 90686 |
|
1,667 |
1,572 |
$37K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,589 |
1,362 |
$36K |
| D1206 |
Topical application of fluoride varnish |
1,095 |
1,044 |
$26K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,355 |
1,237 |
$25K |
| 90648 |
|
1,134 |
1,069 |
$25K |
| 90677 |
|
120 |
112 |
$24K |
| 90670 |
|
928 |
877 |
$21K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
783 |
714 |
$18K |
| 96127 |
|
3,647 |
3,511 |
$17K |
| 90723 |
|
712 |
669 |
$15K |
| 90633 |
|
525 |
499 |
$12K |
| 90680 |
|
437 |
408 |
$9K |
| 94760 |
|
3,970 |
3,324 |
$9K |
| 90651 |
|
258 |
252 |
$6K |
| 0071A |
|
145 |
140 |
$6K |
| 99173 |
|
2,125 |
2,054 |
$5K |
| 0072A |
|
124 |
123 |
$5K |
| 69210 |
|
156 |
120 |
$5K |
| 83655 |
|
329 |
302 |
$4K |
| 90734 |
|
145 |
142 |
$3K |
| 0002A |
|
78 |
77 |
$3K |
| 90656 |
|
143 |
138 |
$3K |
| 36415 |
Collection of venous blood by venipuncture |
789 |
708 |
$3K |
| 0001A |
|
68 |
67 |
$3K |
| 87807 |
|
229 |
208 |
$3K |
| 92567 |
|
125 |
115 |
$2K |
| G2024 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source |
81 |
79 |
$2K |
| 92550 |
|
59 |
58 |
$1K |
| 0004A |
|
32 |
32 |
$1K |
| 81003 |
|
615 |
580 |
$1K |
| 90716 |
|
40 |
40 |
$931.20 |
| 90715 |
|
38 |
38 |
$861.36 |
| 96161 |
|
335 |
297 |
$856.30 |
| 85018 |
|
384 |
351 |
$828.59 |
| 90685 |
|
36 |
34 |
$768.24 |
| 90655 |
|
34 |
33 |
$768.24 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
72 |
62 |
$692.54 |
| 90707 |
|
26 |
26 |
$605.28 |
| 90710 |
|
27 |
26 |
$605.28 |
| 90620 |
|
27 |
25 |
$582.00 |
| 81000 |
|
126 |
119 |
$397.12 |
| 90696 |
|
15 |
14 |
$325.92 |
| A7015 |
Aerosol mask, used with dme nebulizer |
86 |
76 |
$274.96 |
| 97802 |
|
44 |
41 |
$273.27 |
| 97803 |
|
59 |
55 |
$84.33 |
| 36416 |
|
177 |
146 |
$30.00 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
35 |
28 |
$0.00 |